UMd., UMB part of new pharmaceutical research, manufacturing effort
The University of Maryland, College Park and University of Maryland, Baltimore will be partners in a new institute – the National Institute for Innovation of Manufacturing Biopharmaceuticals – to advance U.S. pharmaceutical manufacturing. The creation of the institute was announced by Penny Pritzker, U.S. Secretary of Commerce, in December.
A team of more than 150 companies, educational institutions, nonprofits and state governments will run the institute, supported by millions in funding, including a $250 million investment and a $70 million federal investment.
The National Institute for Innovation of Manufacturing Biopharmaceuticals will concentrate on bringing safe biopharmaceutical products to market faster and on developing workforce training. The biopharma industry is growing quickly with more jobs available than there are qualified workers.
